GlaxoSmithKline Pakistan Limited’s board meeting

Karachi, July 31, 2013 (PPI-OT): Please refer to the Karachi Stock Exchange letter (Re No. KSE/Gen-4064) dated July 25, 2013 and also our letter dated July 30, 2013.

We wish to inform Karachi Stock Exchange Limited that in this meeting the Board of Directors of GSK Pakistan gave its approval to the management to evaluate and pursue business development and investment opportunities, with the intent of re-balancing GSK Pakistan product portfolio and sustaining margins which are being negatively impacted by inflation and devaluation.

These investment opportunities (if materialized) are likely to have a minor but positive impact on the business, which is likely to be less than 10% of turnover.

For more information, contact:
Shahid Qureshi
Director/ Company Secretary
GlaxoSmithKline Pakistan Limited
35-Dockyard Road, West Wharf,
Karachi-74000, Pakistan
UAN: 111-475-725
Tel: 92-21 32315478-82
Fax: 92-21 32314898